Phase 3 Trial Investigating Onivyde for Small Cell Lung Cancer Fails to Meet Primary End Point
August 23rd 2022Irinotecan liposomal injection (Onivyde) used as second-line therapy for patients with small cell lung cancer did not meet the primary end point of overall survival compared to topotecan.
Read More
NCPA CEO: Three-Quarters of Community Pharmacists Say Filling Open Positions Remains Difficult
August 19th 2022Douglas Hoey, PharmD, MBA, CEO of National Community Pharmacists Association (NCPA), discusses potential causes and solutions for the current staffing issues facing so many community pharmacies.
Watch